Immunohematology Market By Product (Analyzers and Systems, Reagents) , By Application (Blood-related Diseases, HIV, Others) By End User (Hospitals, Diagnostic Laboratories, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
The global immunohematology market was valued at $1.9 billion in 2023, and is projected to reach $3.0 billion by 2033, growing at a CAGR of 4.6% from 2024 to 2033.
Immunohematology, also known as blood banking or transfusion medicine, is a specialized branch of laboratory medicine that focuses on the study of blood groups and antibodies associated with blood transfusion. It involves the identification and characterization of blood group antigens on the surface of red blood cells and the corresponding antibodies present in plasma. The main goal of immunohematology is to ensure safe and compatible blood transfusions by matching the blood type of the donor with that of the recipient to prevent adverse reactions. This field plays a crucial role in transfusion therapy, organ transplantation, and managing various hematologic disorders.
The growth of the global immunohematology market is driven by rise in the prevalence of chronic diseases and surge in the number of surgical procedures, which have significantly boosted the need for accurate blood typing and cross-matching, which are crucial for safe transfusion practices. In addition, aging population has led to a higher incidence of conditions such as anemia and leukemia, further escalating the demand for immunohematology products. Moreover, rise in awareness and stringent regulations regarding blood safety and donor compatibility are contributing to the expansion of immunohematology market growth.
However, high cost associated with advanced immunohematology instruments and reagents, which can limit their adoption, especially in developing regions with limited healthcare budgets. On the other hand, adoption of automated and digital blood testing platforms offers significant potential for improving diagnostic accuracy and efficiency, catering to the growing demand for rapid and reliable blood typing and cross-matching. For instance, in May 2023, Bio-Rad Laboratories, Inc. announced the launch of the IH-500TM NEXT System, a fully automated system for ID-Cards. The IH-500 NEXT System is used with Bio-Rad's ID-Cards, offering a broad portfolio for both routine testing (type and screen) and specialized testing, including single antigen determination and newborn screening.
Segmentation Overview
The global immunohematology market is segmented into product, application, end user, and region. Depending on the product, the market is categorized into analyzers & systems and reagents. By application, it is classified into blood-related diseases, HIV, and others. According to end user, the market is divided into hospitals, diagnostic Laboratories, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By product, the reagents segment held the highest share in the market in 2023.
Depending on the application, the blood-related diseases segment accounted for the maximum market share in 2023.
According to end user, the hospitals segment was the largest shareholder in 2023.
Region wise, North America dominated the global immunohematology market in 2023.
Competitive Scenario
The major players operating in the immunohematology market include Bio-Rad Laboratories, Inc, Werfen, Grifols, S.A., Danaher Corporation, Siemens, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, and Cardinal Health. These players have adopted several tactics such as product advancement & diversification, mergers & acquisitions, partnerships, collaborations, and advertising to strengthen their position in the competitive environment.
Key Market Segments
By Product
Analyzers and Systems
Reagents
By Application
Blood-related Diseases
HIV
Others
By End User
Hospitals
Diagnostic Laboratories
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Bio-Rad Laboratories, Inc
Werfen
Grifols, S.A.
Danaher Corporation
Siemens
Thermo Fisher Scientific Inc.
Abbott Laboratories
Merck KGaA
F. Hoffmann-La Roche Ltd
Cardinal Health
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
- CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
- CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
- CHAPTER 4: IMMUNOHEMATOLOGY MARKET, BY PRODUCT
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Product
- 4.2. Analyzers And Systems
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.3. Reagents
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- CHAPTER 5: IMMUNOHEMATOLOGY MARKET, BY APPLICATION
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Application
- 5.2. Blood-related Diseases
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. HIV
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
- 5.4. Others
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country
- CHAPTER 6: IMMUNOHEMATOLOGY MARKET, BY END USER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By End User
- 6.2. Hospitals
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Diagnostic Laboratories
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
- CHAPTER 7: IMMUNOHEMATOLOGY MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Immunohematology Market
- 7.2.6.1. Market Size and Forecast, By Product
- 7.2.6.2. Market Size and Forecast, By Application
- 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Immunohematology Market
- 7.2.7.1. Market Size and Forecast, By Product
- 7.2.7.2. Market Size and Forecast, By Application
- 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Immunohematology Market
- 7.2.8.1. Market Size and Forecast, By Product
- 7.2.8.2. Market Size and Forecast, By Application
- 7.2.8.3. Market Size and Forecast, By End User
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Immunohematology Market
- 7.3.6.1. Market Size and Forecast, By Product
- 7.3.6.2. Market Size and Forecast, By Application
- 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Immunohematology Market
- 7.3.7.1. Market Size and Forecast, By Product
- 7.3.7.2. Market Size and Forecast, By Application
- 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. UK Immunohematology Market
- 7.3.8.1. Market Size and Forecast, By Product
- 7.3.8.2. Market Size and Forecast, By Application
- 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Immunohematology Market
- 7.3.9.1. Market Size and Forecast, By Product
- 7.3.9.2. Market Size and Forecast, By Application
- 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Immunohematology Market
- 7.3.10.1. Market Size and Forecast, By Product
- 7.3.10.2. Market Size and Forecast, By Application
- 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Immunohematology Market
- 7.3.11.1. Market Size and Forecast, By Product
- 7.3.11.2. Market Size and Forecast, By Application
- 7.3.11.3. Market Size and Forecast, By End User
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Immunohematology Market
- 7.4.6.1. Market Size and Forecast, By Product
- 7.4.6.2. Market Size and Forecast, By Application
- 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Immunohematology Market
- 7.4.7.1. Market Size and Forecast, By Product
- 7.4.7.2. Market Size and Forecast, By Application
- 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. India Immunohematology Market
- 7.4.8.1. Market Size and Forecast, By Product
- 7.4.8.2. Market Size and Forecast, By Application
- 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. Australia Immunohematology Market
- 7.4.9.1. Market Size and Forecast, By Product
- 7.4.9.2. Market Size and Forecast, By Application
- 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Immunohematology Market
- 7.4.10.1. Market Size and Forecast, By Product
- 7.4.10.2. Market Size and Forecast, By Application
- 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia-Pacific Immunohematology Market
- 7.4.11.1. Market Size and Forecast, By Product
- 7.4.11.2. Market Size and Forecast, By Application
- 7.4.11.3. Market Size and Forecast, By End User
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Immunohematology Market
- 7.5.6.1. Market Size and Forecast, By Product
- 7.5.6.2. Market Size and Forecast, By Application
- 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. Saudi Arabia Immunohematology Market
- 7.5.7.1. Market Size and Forecast, By Product
- 7.5.7.2. Market Size and Forecast, By Application
- 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. South Africa Immunohematology Market
- 7.5.8.1. Market Size and Forecast, By Product
- 7.5.8.2. Market Size and Forecast, By Application
- 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Immunohematology Market
- 7.5.9.1. Market Size and Forecast, By Product
- 7.5.9.2. Market Size and Forecast, By Application
- 7.5.9.3. Market Size and Forecast, By End User
- CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping Of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
- CHAPTER 9: COMPANY PROFILES
- 9.1. Bio-Rad Laboratories, Inc
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Werfen
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Grifols, S.A.
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Danaher Corporation
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. Siemens
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Thermo Fisher Scientific Inc.
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Abbott Laboratories
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Merck KGaA
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. F. Hoffmann-La Roche Ltd
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Cardinal Health
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1. GLOBAL IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 2. IMMUNOHEMATOLOGY MARKET FOR ANALYZERS AND SYSTEMS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 3. IMMUNOHEMATOLOGY MARKET FOR REAGENTS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 4. GLOBAL IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 5. IMMUNOHEMATOLOGY MARKET FOR BLOOD-RELATED DISEASES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 6. IMMUNOHEMATOLOGY MARKET FOR HIV, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 7. IMMUNOHEMATOLOGY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 8. GLOBAL IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 9. IMMUNOHEMATOLOGY MARKET FOR HOSPITALS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 10. IMMUNOHEMATOLOGY MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 11. IMMUNOHEMATOLOGY MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 12. IMMUNOHEMATOLOGY MARKET, BY REGION, 2024 - 2033 ($BILLION)
- TABLE 13. NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 14. NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 15. NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 16. NORTH AMERICA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 17. U.S. IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 18. U.S. IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 19. U.S. IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 20. CANADA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 21. CANADA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 22. CANADA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 23. MEXICO IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 24. MEXICO IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 25. MEXICO IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 26. EUROPE IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 27. EUROPE IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 28. EUROPE IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 29. EUROPE IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 30. GERMANY IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 31. GERMANY IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 32. GERMANY IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 33. FRANCE IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 34. FRANCE IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 35. FRANCE IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 36. UK IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 37. UK IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 38. UK IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 39. ITALY IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 40. ITALY IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 41. ITALY IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 42. SPAIN IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 43. SPAIN IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 44. SPAIN IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 45. REST OF EUROPE IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 46. REST OF EUROPE IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 47. REST OF EUROPE IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 48. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 49. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 50. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 51. ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 52. JAPAN IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 53. JAPAN IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 54. JAPAN IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 55. CHINA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 56. CHINA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 57. CHINA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 58. INDIA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 59. INDIA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 60. INDIA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 61. AUSTRALIA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 62. AUSTRALIA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 63. AUSTRALIA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 64. SOUTH KOREA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 65. SOUTH KOREA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 66. SOUTH KOREA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 67. REST OF ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 68. REST OF ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 69. REST OF ASIA-PACIFIC IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 70. LAMEA IMMUNOHEMATOLOGY MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
- TABLE 71. LAMEA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 72. LAMEA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 73. LAMEA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 74. BRAZIL IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 75. BRAZIL IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 76. BRAZIL IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 77. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 78. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 79. SAUDI ARABIA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 80. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 81. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 82. SOUTH AFRICA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 83. REST OF LAMEA IMMUNOHEMATOLOGY MARKET, BY PRODUCT, 2024 - 2033 ($BILLION)
- TABLE 84. REST OF LAMEA IMMUNOHEMATOLOGY MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
- TABLE 85. REST OF LAMEA IMMUNOHEMATOLOGY MARKET, BY END USER, 2024 - 2033 ($BILLION)
- TABLE 86. BIO-RAD LABORATORIES, INC: KEY EXECUTIVES
- TABLE 87. BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT
- TABLE 88. BIO-RAD LABORATORIES, INC: OPERATING SEGMENTS
- TABLE 89. BIO-RAD LABORATORIES, INC: PRODUCT PORTFOLIO
- TABLE 90. BIO-RAD LABORATORIES, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 91. WERFEN : KEY EXECUTIVES
- TABLE 92. WERFEN : COMPANY SNAPSHOT
- TABLE 93. WERFEN : OPERATING SEGMENTS
- TABLE 94. WERFEN : PRODUCT PORTFOLIO
- TABLE 95. WERFEN : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 96. GRIFOLS, S.A. : KEY EXECUTIVES
- TABLE 97. GRIFOLS, S.A. : COMPANY SNAPSHOT
- TABLE 98. GRIFOLS, S.A. : OPERATING SEGMENTS
- TABLE 99. GRIFOLS, S.A. : PRODUCT PORTFOLIO
- TABLE 100. GRIFOLS, S.A. : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 101. DANAHER CORPORATION: KEY EXECUTIVES
- TABLE 102. DANAHER CORPORATION: COMPANY SNAPSHOT
- TABLE 103. DANAHER CORPORATION: OPERATING SEGMENTS
- TABLE 104. DANAHER CORPORATION: PRODUCT PORTFOLIO
- TABLE 105. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 106. SIEMENS : KEY EXECUTIVES
- TABLE 107. SIEMENS : COMPANY SNAPSHOT
- TABLE 108. SIEMENS : OPERATING SEGMENTS
- TABLE 109. SIEMENS : PRODUCT PORTFOLIO
- TABLE 110. SIEMENS : KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 111. THERMO FISHER SCIENTIFIC INC.: KEY EXECUTIVES
- TABLE 112. THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
- TABLE 113. THERMO FISHER SCIENTIFIC INC.: OPERATING SEGMENTS
- TABLE 114. THERMO FISHER SCIENTIFIC INC.: PRODUCT PORTFOLIO
- TABLE 115. THERMO FISHER SCIENTIFIC INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 116. ABBOTT LABORATORIES: KEY EXECUTIVES
- TABLE 117. ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 118. ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 119. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 120. ABBOTT LABORATORIES: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 121. MERCK KGAA: KEY EXECUTIVES
- TABLE 122. MERCK KGAA: COMPANY SNAPSHOT
- TABLE 123. MERCK KGAA: OPERATING SEGMENTS
- TABLE 124. MERCK KGAA: PRODUCT PORTFOLIO
- TABLE 125. MERCK KGAA: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 126. F. HOFFMANN-LA ROCHE LTD: KEY EXECUTIVES
- TABLE 127. F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
- TABLE 128. F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
- TABLE 129. F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
- TABLE 130. F. HOFFMANN-LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 131. CARDINAL HEALTH: KEY EXECUTIVES
- TABLE 132. CARDINAL HEALTH: COMPANY SNAPSHOT
- TABLE 133. CARDINAL HEALTH: OPERATING SEGMENTS
- TABLE 134. CARDINAL HEALTH: PRODUCT PORTFOLIO
- TABLE 135. CARDINAL HEALTH: KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1. GLOBAL IMMUNOHEMATOLOGY MARKET, 2024 - 2033
- FIGURE 2. SEGMENTATION OF IMMUNOHEMATOLOGY MARKET, 2024 - 2033
- FIGURE 3. TOP INVESTMENT POCKET IN IMMUNOHEMATOLOGY MARKET
- FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
- FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
- FIGURE 7. LOW THREAT OF SUBSTITUTION
- FIGURE 8. HIGH COMPETITIVE RIVALRY
- FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALIMMUNOHEMATOLOGY MARKET
- FIGURE 10. GLOBAL IMMUNOHEMATOLOGY MARKET SEGMENTATION, BY PRODUCT
- FIGURE 11. IMMUNOHEMATOLOGY MARKET FOR ANALYZERS AND SYSTEMS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 12. IMMUNOHEMATOLOGY MARKET FOR REAGENTS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 13. GLOBAL IMMUNOHEMATOLOGY MARKET SEGMENTATION, BY APPLICATION
- FIGURE 14. IMMUNOHEMATOLOGY MARKET FOR BLOOD-RELATED DISEASES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 15. IMMUNOHEMATOLOGY MARKET FOR HIV, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 16. IMMUNOHEMATOLOGY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 17. GLOBAL IMMUNOHEMATOLOGY MARKET SEGMENTATION, BY END USER
- FIGURE 18. IMMUNOHEMATOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 19. IMMUNOHEMATOLOGY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 20. IMMUNOHEMATOLOGY MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
- FIGURE 21. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
- FIGURE 22. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
- FIGURE 23. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
- FIGURE 24. PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 25. COMPETITIVE DASHBOARD
- FIGURE 26. COMPETITIVE HEATMAP: IMMUNOHEMATOLOGY MARKET
- FIGURE 27. TOP PLAYER POSITIONING, 2023
- FIGURE 28. BIO-RAD LABORATORIES, INC: NET SALES, 2021-2023 ($BILLION)
- FIGURE 29. BIO-RAD LABORATORIES, INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 30. BIO-RAD LABORATORIES, INC: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 31. WERFEN : NET SALES, 2021-2023 ($BILLION)
- FIGURE 32. WERFEN : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 33. WERFEN : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 34. GRIFOLS, S.A. : NET SALES, 2021-2023 ($BILLION)
- FIGURE 35. GRIFOLS, S.A. : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 36. GRIFOLS, S.A. : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 37. DANAHER CORPORATION: NET SALES, 2021-2023 ($BILLION)
- FIGURE 38. DANAHER CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 39. DANAHER CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 40. SIEMENS : NET SALES, 2021-2023 ($BILLION)
- FIGURE 41. SIEMENS : REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 42. SIEMENS : REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 43. THERMO FISHER SCIENTIFIC INC.: NET SALES, 2021-2023 ($BILLION)
- FIGURE 44. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 45. THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 46. ABBOTT LABORATORIES: NET SALES, 2021-2023 ($BILLION)
- FIGURE 47. ABBOTT LABORATORIES: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 48. ABBOTT LABORATORIES: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 49. MERCK KGAA: NET SALES, 2021-2023 ($BILLION)
- FIGURE 50. MERCK KGAA: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 51. MERCK KGAA: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 52. F. HOFFMANN-LA ROCHE LTD: NET SALES, 2021-2023 ($BILLION)
- FIGURE 53. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 54. F. HOFFMANN-LA ROCHE LTD: REVENUE SHARE, BY REGION, 2023 (%)
- FIGURE 55. CARDINAL HEALTH: NET SALES, 2021-2023 ($BILLION)
- FIGURE 56. CARDINAL HEALTH: REVENUE SHARE, BY SEGMENT, 2023 (%)
- FIGURE 57. CARDINAL HEALTH: REVENUE SHARE, BY REGION, 2023 (%)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook